Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Research in Social & Administrative Pharmacy : RSAP|December 13, 2006
Development and validation of a scale to assess attitudes of health care administrators toward the use of e-mail communication between patients and physiciansMenaka Bhor, Holly L Mason
Journal of Health Economics and Outcomes Research|July 21, 2020
Medical Resource Use and Costs of Treating Sickle Cell-related Vaso-occlusive Crisis Episodes: A Retrospective Claims StudyNirmish Shah, Menaka Bhor, Lin Xie, et al.
Plos One|July 6, 2019
Sickle cell disease complications: Prevalence and resource utilizationNirmish Shah, Menaka Bhor, Lin Xie, et al.
Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002)|September 2, 2009
Obstacles and proposed solutions to effective antiretroviral therapy in resource-limited settingsJohn A Bartlett, John Hornberger, Ashwini Shewade, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
High Healthcare Utilization in Adolescents with Sickle Cell Disease Prior to Transition to Adult Care: A Retrospective StudyJulie Kanter, Menaka Bhor, Xin Li, et al.
Clinical Genitourinary Cancer|October 16, 2012
Everolimus vs. temsirolimus for advanced renal cell carcinoma: use and use of resources in the US Oncology NetworkNicholas J Vogelzang, Menaka Bhor, Zhimei Liu, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopeniaGabriel Tremblay, Mike Dolph, Menaka Bhor, et al.
International Journal of General Medicine|August 6, 2020
Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic ReviewSoyon Lee, Diana K Vania, Menaka Bhor, et al.
Journal of Health Economics and Outcomes Research|July 21, 2020
Evaluation of Vaso-occlusive Crises in United States Sickle Cell Disease Patients: A Retrospective Claims-based StudyNirmish Shah, Menaka Bhor, Lin Xie, et al.
Health and Quality of Life Outcomes|October 18, 2019
Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based studyNirmish Shah, Menaka Bhor, Lin Xie, et al.
Pageof 3